Integrative Analysis of Large-cell Lung Cancer
Recruiting · NCT02917369 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Normal lung tissue
What this trial is about
Integrative analysis of LCLC
Who can take part
Age range
18 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age ≤ 75 years with histologically proven LCLC
- No severe major organ dysfunction
- World Health Organization (WHO) performance status of 0 or 1
- No prior cancer chemotherapy
Exclusion criteria
- Age ≥ 76
- Severe major organ dysfunction
- WHO performance status of \>1
- Prior cancer chemotherapy
Where it is running
3 locations listed.
- Ganzhou City People's Hospital - Ganzhou, Jiangxi, China
- Shanghai Tenth People's Hospital - Shanghai, Shanghai Municipality, China
- Shanghai Pulmonary Hospital - Shanghai, Shanghai Municipality, China